Följ
Dr. Baddipadige Raju Reddy
Dr. Baddipadige Raju Reddy
Verifierad e-postadress på ils.res.in
Titel
Citeras av
Citeras av
År
Multiple machine learning, molecular docking, and ADMET screening approach for identification of selective inhibitors of CYP1B1
B Raju, H Verma, G Narendra, B Sapra, O Silakari
Journal of Biomolecular Structure and Dynamics 40 (17), 7975-7990, 2022
182022
Role of genetic polymorphisms in drug-metabolizing enzyme-mediated toxicity and pharmacokinetic resistance to anti-cancer agents: a review on the pharmacogenomics aspect
G Narendra, S Choudhary, B Raju, H Verma, O Silakari
Clinical Pharmacokinetics 61 (11), 1495-1517, 2022
152022
Dihydropyrimidine dehydrogenase-mediated resistance to 5-fluorouracil: Mechanistic investigation and solution
H Verma, G Narendra, B Raju, PK Singh, O Silakari
ACS Pharmacology & Translational Science 5 (11), 1017-1033, 2022
132022
Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review
B Raju, S Choudhary, G Narendra, H Verma, O Silakari
Drug Metabolism Reviews 53 (1), 45-75, 2021
132021
Multiple machine learning models combined with virtual screening and molecular docking to identify selective human ALDH1A1 inhibitors
G Narendra, B Raju, H Verma, B Sapra, O Silakari
Journal of Molecular Graphics and Modelling 107, 107950, 2021
122021
3D‐QSAR and scaffold hopping based designing of benzo[d]ox‐azol‐2(3H)‐one and 2‐oxazolo[4,5‐b]pyridin‐2(3H)‐one derivatives as selective aldehyde …
H Verma, G Narendra, B Raju, M Kumar, SK Jain, GK Tung, PK Singh, ...
Archiv der Pharmazie 355 (9), 2200108, 2022
112022
Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis
Gera Narendra, Baddipadige Raju, Himanshu Verma, Om Silakari
Medical Oncology 38 (123), 1-10, 2021
92021
QM/MM studies on enzyme catalysis and insight into designing of new inhibitors by ONIOM approach: recent update
H Sharma, B Raju, G Narendra, M Motiwale, B Sharma, H Verma, ...
ChemistrySelect 8 (1), e202203319, 2023
62023
Machine learning enabled structure-based drug repurposing approach to identify potential CYP1B1 inhibitors
B Raju, G Narendra, H Verma, M Kumar, B Sapra, G Kaur, SK Jain, ...
ACS omega 7 (36), 31999-32013, 2022
52022
3D-QSAR assisted identification of selective CYP1B1 inhibitors: An effective bioisosteric replacement/molecular docking/electrostatic complementarity analysis
B Raju, B Sapra, O Silakari
Molecular Diversity 27 (6), 2673-2693, 2023
42023
Identification of chemoresistance associated key genes-miRNAs-TFs in docetaxel resistant breast cancer by bioinformatics analysis
B Raju, G Narendra, H Verma, O Silakari
3 Biotech 14 (5), 128, 2024
32024
Classification of Potent and Weak Penetration Enhancers Using Multiple Feature Selection Methods and Machine Learning Models
Baddipadige Raju, Neha Verma, Gera Narendra, Om Silakari1, Bharti Sapra
Journal of Pharmaceutical Innovation, 2023
32023
Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach
G Narendra, B Raju, H Verma, M Kumar, SK Jain, GK Tung, S Thakur, ...
International Journal of Biological Macromolecules 242, 124749, 2023
32023
In silico guided designing of optimized benzochalcones derivatives as potent CYP1B1 inhibitors: An integrated in vitro and ONIOM study
H Sharma, B Raju, G Narendra, M Kumar, H Verma, B Sharma, GK Tung, ...
Journal of Molecular Graphics and Modelling 119, 108390, 2023
32023
Identification of potential benzoxazolinones as CYP1B1 inhibitors via molecular docking, dynamics, waterswap, and in vitro analysis
B Raju, H Verma, G Narendra, G Kaur, SK Jain, O Silakari
New Journal of Chemistry 47 (26), 12339-12349, 2023
32023
Bioactive molecules isolated from Cymbopogon flexuosus and Monarda citriodora essential oils: Chemical profiling, antimycotic potential, and molecular docking studies against …
Rashmi, Ritu Tandon, Anu Kalia, Baddipadige Raju, Om Silakari
Journal of Essential Oil Bearing Plants 27 (4), 2024
22024
Scaffold hopping for designing of potent and selective CYP1B1 inhibitors to overcome docetaxel resistance: synthesis and evaluation
B Raju, G Narendra, H Verma, M Kumar, B Sapra, G Kaur, SK Jain, ...
Journal of Biomolecular Structure and Dynamics, 1-19, 2024
22024
Evaluation of Cordyceps militaris steroids as antiinflammatory agents to combat the Covid-19 cytokine storm: a bioinformatics and structurebased drug designing approach
Manmeet Singh, Himanshu Verma, Narendra Gera, Raju Baddipadige, Shalki ...
Journal of Biomolecular Structure and Dynamics, 2023
2*2023
Identification of natural peptides from “PlantPepDB” database as anti-SARS-CoV-2 agents: A protein-protein docking approach
P Bhandu, H Verma, B Raju, G Narendra, S Choudhary, M Singh, ...
Phytomedicine Plus 3 (2), 100446, 2023
22023
Identification of kinase inhibitors that rule out the CYP27B1-mediated activation of vitamin D: an integrated machine learning and structure-based drug designing approach
K Mahajan, H Verma, S Choudhary, B Raju, O Silakari
Molecular Diversity 25, 1617-1641, 2021
22021
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20